Press Releases

Please find the latest press releases from Avextra here.

Avextra und die Deutsche Gesellschaft für Schmerzmedizin – mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Avextra und die Deutsche Gesellschaft für Schmerzmedizin – mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Deutschland legt Plan zur begrenzten Legalisierung von Cannabis für den Freizeitgebrauch in abgestufter Form vor.

Deutschland legt Plan zur begrenzten Legalisierung von Cannabis für den Freizeitgebrauch in abgestufter Form vor.

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

Avextra AG Announces Closing of EU 17 Million Capital Raise

Avextra AG Announces Closing of EU 17 Million Capital Raise

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra erweitert Cannabis-Portfolio um neue Dronabinol-Lösung

Avextra erweitert Cannabis-Portfolio um neue Dronabinol-Lösung

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom

Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom

Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Die Unternehmen haben es sich zum Ziel gesetzt, das erste Inhalationsdevice zur Verabreichung von standardisierten Cannabisextrakten…

Medical Device Submission for a Cannabis Extract Inhaler

Medical Device Submission for a Cannabis Extract Inhaler

Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Die Unternehmen haben es sich zum Ziel gesetzt, das erste Inhalationsdevice zur Verabreichung von standardisierten Cannabisextrakten…

Eurox has rebranded as Avextra

Eurox has rebranded as Avextra

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Germany unveils scaled-down recreational cannabis legalization plan

Germany unveils scaled-down recreational cannabis legalization plan

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

Avextra AG Announces Closing of EU 17 Million Capital Raise

Avextra AG Announces Closing of EU 17 Million Capital Raise

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…

Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom

Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom

Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Die Unternehmen haben es sich zum Ziel gesetzt, das erste Inhalationsdevice zur Verabreichung von standardisierten Cannabisextrakten…

Medical Device Submission for a Cannabis Extract Inhaler

Medical Device Submission for a Cannabis Extract Inhaler

Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Die Unternehmen haben es sich zum Ziel gesetzt, das erste Inhalationsdevice zur Verabreichung von standardisierten Cannabisextrakten…

Eurox has rebranded as Avextra

Eurox has rebranded as Avextra

Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the…

New board member at Eurox AG: Marla Luther is Chief Strategy Officer

New board member at Eurox AG: Marla Luther is Chief Strategy Officer

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…

PRESS CONTaCT

Lisa Schwede

Tel.: +49 30 408174037

E-Mail: press@avextra.com

EN